Institut d'Investigació Biomèdica de Bellvitge
Clinical Trials
16
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Weight Management in Obese Cancer Patients During Curative Active Treatment
- Conditions
- ObesitySolid NeoplasmStage II-IVCurative Treatment
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Target Recruit Count
- 50
- Registration Number
- NCT07058207
- Locations
- 🇪🇸
Institut Català d'Oncologia. Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain
Patient-centered Personalized Cardiac Rehabilitation in Post Acute Coronary Syndrome (BREAK-trial)
- Conditions
- Acute Coronary Syndromes (ACS)Cardiac RehabilitationFrailtyWomenWomen's Health
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Target Recruit Count
- 202
- Registration Number
- NCT07038265
- Locations
- 🇪🇸
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
Reversibility of Cardiac Conduction Disturbances Following TAVI
- Conditions
- Transcatheter Aortic Valve ImplantationAortic StenosisConduction Disturbances
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Target Recruit Count
- 209
- Registration Number
- NCT06481137
- Locations
- 🇪🇸
Hospital Universitari de Bellvitge, L' Hospitalet De Llobregat, Barcelona, Spain
Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
- Conditions
- Complete Heart BlockSecond Degree Atrioventricular Block Möbitz Type II
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Target Recruit Count
- 326
- Registration Number
- NCT06474819
- Locations
- 🇪🇸
Hospital Vall d'Hebrón, Barcelona, Spain
🇪🇸Hospital General Universitario de Castellón, Castellón De La Plana, Spain
🇪🇸Hospital Virgen de las Nieves, Granada, Spain
Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)
- Conditions
- Interstitial Lung DiseaseInterstitial Fibrosis
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Target Recruit Count
- 1000
- Registration Number
- NCT05998512
- Locations
- 🇪🇸
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital La Princesa, Madrid, Spain
🇪🇸Hospital Virgen del Rocío, Sevilla, Spain
- Prev
- 1
- 2
- 3
- 4
- Next